Purpose
Therapeutic Drug Monitoring
Method(s)
High Performance Liquid Chromatography (HPLC)
Suggested CPT Code(s)
80375
New York State Approval Status

Approved

Turnaround Time

8 days

Test Includes
1 Levodopa Sinemet Constituent High Performance Liquid Chromatography (HPLC) mcg/mL 0.02 Antiparkinson
2 Carbidopa Sinemet Constituent High Performance Liquid Chromatography (HPLC) mcg/mL 0.02 Antiparkinson

Test Also Known As
Dopar®; L-Dopa; Larodopa®; Sinemet®
Specimen Type
Serum or Plasma
Requested Volume
2 mL
Minimum Volume
0.7 mL
Special Handling
Serum: Collect sample in Red top tube
Plasma: Collect sample in Lavender top tube (EDTA) or Pink top tube.
Promptly centrifuge and separate Serum or Plasma into a plastic screw capped vial using approved guidelines.
Specimen Container
Plastic container (preservative-free)

Additional Collection Instructions

Transport Temperature
Frozen
Light Protection
Not Required
Rejection Criteria
Received Room Temperature. Received Refrigerated. Polymer gel separation tube (SST or PST).

Rejection criteria pertain to clinical specimen submissions only.

Stability
Room Temperature: Not Stable
Refrigerated: Not Stable
Frozen (-20 °C): 30 day(s)
1 Levodopa Sinemet Constituent High Performance Liquid Chromatography (HPLC) mcg/mL 0.02 Antiparkinson
2 Carbidopa Sinemet Constituent High Performance Liquid Chromatography (HPLC) mcg/mL 0.02 Antiparkinson

Interface Map

LOINC® Information